Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | PNP | P00491 | 2/20 | 0.36 |
| ▸ | CDK2 | P24941 | 2/20 | 0.35 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | CDK7 | P50613 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | CCNH | P51946 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17265808 | 0.69 | ALDH1A1 (0.52) | ALDH1A1KDM4ERXFP1CDK2PAK1 | |
| SCHEMBL10401760 | 0.67 | — | — | |
| SCHEMBL20830163 | 0.67 | SMN1; SMN2 (0.38) | ALDH1A1HTT | |
| SCHEMBL276944 | 0.65 | ALDH1A1 (0.59) | ALDH1A1KDM4ERXFP1PNPCDK2 | |
| SCHEMBL2008297 | 0.65 | ALDH1A1 (0.44) | ALDH1A1KDM4ERXFP1PNPCDK2 | |
| SCHEMBL29452971 | 0.64 | ALDH1A1 (0.63) | ALDH1A1KDM4ERXFP1CDK2PAK1 | |
| SCHEMBL22487731 | 0.63 | L3MBTL1 (0.42) | ALDH1A1 | |
| SCHEMBL29656531 | 0.63 | EGFR (0.32) | — | |
| SCHEMBL10402531 | 0.63 | ALDH1A1 (0.39) | ALDH1A1KDM4EPNPDPP4GAA | |
| SCHEMBL5748057 | 0.62 | ALDH1A1 (0.61) | ALDH1A1KDM4ERXFP1CDK2PAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022062357-A1 | MEDICINE FOR TREATING OR PREVENTING DISEASES RELATED TO ACTIVITY OF LRRK2 KINASE OR ABNORMAL LRRK2 MUTANT KINASE | 广州智睿医药科技有限公司 | 2022-03-31 | — | — | WO | claimed |
| US-12601008-B2 | Using hairpin formation to identify DNA and RNA sequences having a target nucleic acid sequence | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20230419331-A1 | OLIGONUCLEOTIDES REPRESENTING DIGITAL DATA | NUCLEOTRACE PTY LTD (AU) | 2023-12-28 | — | — | US | disclosed |
| CN-117136241-A | Oligonucleotides representing digital data | 核素示踪有限公司 | 2023-11-28 | — | — | CN | disclosed |
| US-20230348962-A1 | Using Hairpin Formation To Identify DNA and RNA Sequences Having A Target Nucleic Acid Sequence | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-11-02 | — | — | US | disclosed |
| EP-4226379-A1 | OLIGONUCLEOTIDES REPRESENTING DIGITAL DATA | Nucleotrace Pty. Ltd. (AU) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023081373-A1 | USING HAIRPIN FORMATION TO IDENTIFY DNA AND RNA SEQUENCES HAVING A TARGET NUCLEIC ACID SEQUENCE | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| EP-4055162-A1 | EVALUATING GENOMIC VARIATION USING REPETITIVE NUCLEIC ACID SEQUENCES | Florida State University Research Foundation, Inc. (US) | 2022-09-14 | — | — | EP | disclosed |
| CN-114641578-A | Apparatus and method for biopolymer identification | 通用测序技术公司 | 2022-06-17 | — | — | CN | disclosed |
| US-20220145377-A1 | Device and Method for Biopolymer Identification | UNIVERSAL SEQUENCING TECHNOLOGY CORPORATION | 2022-05-12 | — | — | US | disclosed |
| WO-2022073063-A1 | OLIGONUCLEOTIDES REPRESENTING DIGITAL DATA | Nucleotrace Pty. Ltd. (AU) | 2022-04-14 | — | — | WO | disclosed |
| WO-2022062357-A1 | MEDICINE FOR TREATING OR PREVENTING DISEASES RELATED TO ACTIVITY OF LRRK2 KINASE OR ABNORMAL LRRK2 MUTANT KINASE | 广州智睿医药科技有限公司 | 2022-03-31 | — | — | WO | disclosed |
| US-20140301947-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | IMPERIAL INNOVATIONS LIMITED (GB) | 2014-10-09 | — | — | US | disclosed |
| EP-2718464-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | Imperial Innovations Limited (GB) | 2014-04-16 | — | — | EP | disclosed |
| WO-2012168697-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | IMPERIAL INNOVATIONS LIMITED (GB) | 2012-12-13 | — | — | WO | disclosed |
| WO-2007103162-A2 | STRUCTURE BASED DRUG DESIGN OF STEROIDOGENESIS INHIBITORS | SAMARITAN PHARMACEUTICALS, INC. (US) | 2007-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140301947-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | TSPO, GPR174, TSG101 | ALDH1A1 2681/4885KDM4E 4857/4885RXFP1 200/4885 |
| US-12601008-B2 | Using hairpin formation to identify DNA and RNA sequences having a target nucleic acid sequence | UPF1, RNGTT, POLRMT | ALDH1A1 2167/4885KDM4E 3924/4885RXFP1 3020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.